» Articles » PMID: 28787641

Functions and Emerging Applications of Bacteriocins

Overview
Publisher Elsevier
Specialty Biotechnology
Date 2017 Aug 9
PMID 28787641
Citations 186
Authors
Affiliations
Soon will be listed here.
Abstract

Bacteriocins, defined as ribosomally synthesized antimicrobial peptides, have traditionally been used as food preservatives, either added or produced by starter cultures during fermentation. In-depth studies of a select few bacteriocins opened exiting new research fields and broadened the application of these antimicrobial peptides. The possibility of developing bacteriocins into next generation antibiotics, accompanied with the rapid development in genetics and nanotechnology, paves the way to even more fascinating applications such as novel carrier molecules (delivery systems) and the treatment of cancer. Also, some bacteriocins are found to regulate quorum sensing which suggests novel applications for this group of substances. While there is some interesting translational research on bacteriocins from Gram-negative bacteria, the majority of application-oriented studies are focused on bacteriocins from Gram-positive microorganisms, mostly lactic acid bacteria. The applications of bacteriocins are expanding from food to human health.

Citing Articles

Optimisation of cultivation conditions for G7 from mangrove plants and exploration of potential bacteriocins.

Li Y, Ma H, Pan R, Long Y, Zhao Y, Yu M Front Pharmacol. 2025; 16:1530043.

PMID: 40078294 PMC: 11897483. DOI: 10.3389/fphar.2025.1530043.


Bactofencin A Displays a Delayed Killing Effect on a Clinical Strain of Which Is Greatly Accelerated in the Presence of Nisin.

OConnor P, Cotter P, Hill C, Ross R Antibiotics (Basel). 2025; 14(2).

PMID: 40001428 PMC: 11851555. DOI: 10.3390/antibiotics14020184.


Lysis of Escherichia coli by colicin Ib contributes to bacterial cross-feeding by releasing active β-galactosidase.

Lerminiaux N, Kaufman J, Schnell L, Workman S, Suchan D, Kroger C ISME J. 2025; 19(1).

PMID: 39969895 PMC: 11896792. DOI: 10.1093/ismejo/wraf032.


Gut Microbiota Secondary Metabolites: Key Roles in GI Tract Cancers and Infectious Diseases.

Anwer E, Ajagbe M, Sherif M, Musaibah A, Mahmoud S, ElBanbi A Biomedicines. 2025; 13(1).

PMID: 39857684 PMC: 11762448. DOI: 10.3390/biomedicines13010100.


A gut-derived produces the novel nisin variant designated nisin G and inhibits in a model of the human distal colon microbiome.

Lawrence G, Garcia-Gutierrez E, OMahony A, Walsh C, OConnor P, Begley M mBio. 2024; 16(2):e0157324.

PMID: 39692472 PMC: 11796361. DOI: 10.1128/mbio.01573-24.


References
1.
Van Staden A, Brand A, Dicks L . Nisin F-loaded brushite bone cement prevented the growth of Staphylococcus aureus in vivo. J Appl Microbiol. 2012; 112(4):831-40. DOI: 10.1111/j.1365-2672.2012.05241.x. View

2.
Hasper H, Kramer N, Smith J, Hillman J, Zachariah C, Kuipers O . An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II. Science. 2006; 313(5793):1636-7. DOI: 10.1126/science.1129818. View

3.
Balasubramanian A, Lee D, Chikindas M, Yam K . Effect of Nisin's Controlled Release on Microbial Growth as Modeled for Micrococcus luteus. Probiotics Antimicrob Proteins. 2016; 3(2):113-8. DOI: 10.1007/s12602-011-9073-8. View

4.
Sundara Rajan S, Cavera V, Zhang X, Singh Y, Chikindas M, Sinko P . Polyethylene glycol-based hydrogels for controlled release of the antimicrobial subtilosin for prophylaxis of bacterial vaginosis. Antimicrob Agents Chemother. 2014; 58(5):2747-53. PMC: 3993243. DOI: 10.1128/AAC.02446-14. View

5.
Ahmad V, Khan M, Jamal Q, Alzohairy M, Al Karaawi M, Siddiqui M . Antimicrobial potential of bacteriocins: in therapy, agriculture and food preservation. Int J Antimicrob Agents. 2016; 49(1):1-11. DOI: 10.1016/j.ijantimicag.2016.08.016. View